img

Global Corticosteroid Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Corticosteroid Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma.
Corticosteroid Medication report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Corticosteroid Medication market is projected to reach US$ 6690.5 million in 2029, increasing from US$ 4850 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Corticosteroid Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson & Johnson
GSK
AstraZeneca
Cipla
LEO Pharma
Abbott Laboratories
Bayer
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Zhejiang Xianju Pharmaceutical Co.,Ltd
Shandong Xinhua Pharmaceutical Company Limited
Yangzi River Pharmaceutical Group
Segment by Type
Tablets
Capsules
Eye Drops
Lotions, Creams, Ointments, or Gels
Nasal or Mouth Sprays
Injections

Segment by Application


Hospital
Clinic
Pharmacy

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Corticosteroid Medication market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Corticosteroid Medication, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Corticosteroid Medication industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Corticosteroid Medication in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Corticosteroid Medication introduction, etc. Corticosteroid Medication Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Corticosteroid Medication market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Corticosteroid Medication Market Overview
1.1 Corticosteroid Medication Product Overview
1.2 Corticosteroid Medication Market Segment by Type
1.2.1 Tablets
1.2.2 Capsules
1.2.3 Eye Drops
1.2.4 Lotions, Creams, Ointments, or Gels
1.2.5 Nasal or Mouth Sprays
1.2.6 Injections
1.3 Global Corticosteroid Medication Market Size by Type
1.3.1 Global Corticosteroid Medication Market Size Overview by Type (2018-2029)
1.3.2 Global Corticosteroid Medication Historic Market Size Review by Type (2018-2024)
1.3.3 Global Corticosteroid Medication Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Corticosteroid Medication Sales Breakdown by Type (2018-2024)
1.4.2 Europe Corticosteroid Medication Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Corticosteroid Medication Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Corticosteroid Medication Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Corticosteroid Medication Sales Breakdown by Type (2018-2024)
2 Global Corticosteroid Medication Market Competition by Company
2.1 Global Top Players by Corticosteroid Medication Sales (2018-2024)
2.2 Global Top Players by Corticosteroid Medication Revenue (2018-2024)
2.3 Global Top Players by Corticosteroid Medication Price (2018-2024)
2.4 Global Top Manufacturers Corticosteroid Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Corticosteroid Medication Market Competitive Situation and Trends
2.5.1 Corticosteroid Medication Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Corticosteroid Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Corticosteroid Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Corticosteroid Medication Market
2.8 Key Manufacturers Corticosteroid Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Corticosteroid Medication Status and Outlook by Region
3.1 Global Corticosteroid Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Corticosteroid Medication Historic Market Size by Region
3.2.1 Global Corticosteroid Medication Sales in Volume by Region (2018-2024)
3.2.2 Global Corticosteroid Medication Sales in Value by Region (2018-2024)
3.2.3 Global Corticosteroid Medication Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Corticosteroid Medication Forecasted Market Size by Region
3.3.1 Global Corticosteroid Medication Sales in Volume by Region (2024-2029)
3.3.2 Global Corticosteroid Medication Sales in Value by Region (2024-2029)
3.3.3 Global Corticosteroid Medication Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Corticosteroid Medication by Application
4.1 Corticosteroid Medication Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Pharmacy
4.2 Global Corticosteroid Medication Market Size by Application
4.2.1 Global Corticosteroid Medication Market Size Overview by Application (2018-2029)
4.2.2 Global Corticosteroid Medication Historic Market Size Review by Application (2018-2024)
4.2.3 Global Corticosteroid Medication Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Corticosteroid Medication Sales Breakdown by Application (2018-2024)
4.3.2 Europe Corticosteroid Medication Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Corticosteroid Medication Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Corticosteroid Medication Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Corticosteroid Medication Sales Breakdown by Application (2018-2024)
5 North America Corticosteroid Medication by Country
5.1 North America Corticosteroid Medication Historic Market Size by Country
5.1.1 North America Corticosteroid Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Corticosteroid Medication Sales in Volume by Country (2018-2024)
5.1.3 North America Corticosteroid Medication Sales in Value by Country (2018-2024)
5.2 North America Corticosteroid Medication Forecasted Market Size by Country
5.2.1 North America Corticosteroid Medication Sales in Volume by Country (2024-2029)
5.2.2 North America Corticosteroid Medication Sales in Value by Country (2024-2029)
6 Europe Corticosteroid Medication by Country
6.1 Europe Corticosteroid Medication Historic Market Size by Country
6.1.1 Europe Corticosteroid Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Corticosteroid Medication Sales in Volume by Country (2018-2024)
6.1.3 Europe Corticosteroid Medication Sales in Value by Country (2018-2024)
6.2 Europe Corticosteroid Medication Forecasted Market Size by Country
6.2.1 Europe Corticosteroid Medication Sales in Volume by Country (2024-2029)
6.2.2 Europe Corticosteroid Medication Sales in Value by Country (2024-2029)
7 Asia-Pacific Corticosteroid Medication by Region
7.1 Asia-Pacific Corticosteroid Medication Historic Market Size by Region
7.1.1 Asia-Pacific Corticosteroid Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Corticosteroid Medication Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Corticosteroid Medication Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Corticosteroid Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Corticosteroid Medication Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Corticosteroid Medication Sales in Value by Region (2024-2029)
8 Latin America Corticosteroid Medication by Country
8.1 Latin America Corticosteroid Medication Historic Market Size by Country
8.1.1 Latin America Corticosteroid Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Corticosteroid Medication Sales in Volume by Country (2018-2024)
8.1.3 Latin America Corticosteroid Medication Sales in Value by Country (2018-2024)
8.2 Latin America Corticosteroid Medication Forecasted Market Size by Country
8.2.1 Latin America Corticosteroid Medication Sales in Volume by Country (2024-2029)
8.2.2 Latin America Corticosteroid Medication Sales in Value by Country (2024-2029)
9 Middle East and Africa Corticosteroid Medication by Country
9.1 Middle East and Africa Corticosteroid Medication Historic Market Size by Country
9.1.1 Middle East and Africa Corticosteroid Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Corticosteroid Medication Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Corticosteroid Medication Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Corticosteroid Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Corticosteroid Medication Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Corticosteroid Medication Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sumitomo
10.1.1 Sumitomo Company Information
10.1.2 Sumitomo Introduction and Business Overview
10.1.3 Sumitomo Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sumitomo Corticosteroid Medication Products Offered
10.1.5 Sumitomo Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Corticosteroid Medication Products Offered
10.2.5 Pfizer Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Corticosteroid Medication Products Offered
10.3.5 Novartis Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Corticosteroid Medication Products Offered
10.4.5 Merck Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Sanofi Corticosteroid Medication Products Offered
10.5.5 Sanofi Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Johnson & Johnson Corticosteroid Medication Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 GSK
10.7.1 GSK Company Information
10.7.2 GSK Introduction and Business Overview
10.7.3 GSK Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.7.4 GSK Corticosteroid Medication Products Offered
10.7.5 GSK Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.8.4 AstraZeneca Corticosteroid Medication Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Cipla
10.9.1 Cipla Company Information
10.9.2 Cipla Introduction and Business Overview
10.9.3 Cipla Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Cipla Corticosteroid Medication Products Offered
10.9.5 Cipla Recent Development
10.10 LEO Pharma
10.10.1 LEO Pharma Company Information
10.10.2 LEO Pharma Introduction and Business Overview
10.10.3 LEO Pharma Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.10.4 LEO Pharma Corticosteroid Medication Products Offered
10.10.5 LEO Pharma Recent Development
10.11 Abbott Laboratories
10.11.1 Abbott Laboratories Company Information
10.11.2 Abbott Laboratories Introduction and Business Overview
10.11.3 Abbott Laboratories Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Abbott Laboratories Corticosteroid Medication Products Offered
10.11.5 Abbott Laboratories Recent Development
10.12 Bayer
10.12.1 Bayer Company Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Bayer Corticosteroid Medication Products Offered
10.12.5 Bayer Recent Development
10.13 Tianjin Tianyao Pharmaceuticals Co., Ltd.
10.13.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information
10.13.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Introduction and Business Overview
10.13.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Products Offered
10.13.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Development
10.14 Zhejiang Xianju Pharmaceutical Co.,Ltd
10.14.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
10.14.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Introduction and Business Overview
10.14.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Products Offered
10.14.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development
10.15 Shandong Xinhua Pharmaceutical Company Limited
10.15.1 Shandong Xinhua Pharmaceutical Company Limited Company Information
10.15.2 Shandong Xinhua Pharmaceutical Company Limited Introduction and Business Overview
10.15.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Products Offered
10.15.5 Shandong Xinhua Pharmaceutical Company Limited Recent Development
10.16 Yangzi River Pharmaceutical Group
10.16.1 Yangzi River Pharmaceutical Group Company Information
10.16.2 Yangzi River Pharmaceutical Group Introduction and Business Overview
10.16.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Yangzi River Pharmaceutical Group Corticosteroid Medication Products Offered
10.16.5 Yangzi River Pharmaceutical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Corticosteroid Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Corticosteroid Medication Industrial Chain Analysis
11.4 Corticosteroid Medication Market Dynamics
11.4.1 Corticosteroid Medication Industry Trends
11.4.2 Corticosteroid Medication Market Drivers
11.4.3 Corticosteroid Medication Market Challenges
11.4.4 Corticosteroid Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Corticosteroid Medication Distributors
12.3 Corticosteroid Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablets
Table 2. Major Company of Capsules
Table 3. Major Company of Eye Drops
Table 4. Major Company of Lotions, Creams, Ointments, or Gels
Table 5. Major Company of Nasal or Mouth Sprays
Table 6. Major Company of Injections
Table 7. Global Corticosteroid Medication Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Corticosteroid Medication Sales by Type (2018-2024) & (K Units)
Table 9. Global Corticosteroid Medication Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Corticosteroid Medication Sales by Type (2018-2024) & (US& Million)
Table 11. Global Corticosteroid Medication Market Share in Value by Type (2018-2024)
Table 12. Global Corticosteroid Medication Price by Type (2018-2024) & (US$/Unit)
Table 13. Global Corticosteroid Medication Sales by Type (2024-2029) & (K Units)
Table 14. Global Corticosteroid Medication Sales Market Share in Volume by Type (2024-2029)
Table 15. Global Corticosteroid Medication Sales by Type (2024-2029) & (US$ Million)
Table 16. Global Corticosteroid Medication Sales Market Share in Value by Type (2024-2029)
Table 17. Global Corticosteroid Medication Price by Type (2024-2029) & (US$/Unit)
Table 18. North America Corticosteroid Medication Sales by Type (2018-2024) & (K Units)
Table 19. North America Corticosteroid Medication Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Corticosteroid Medication Sales (K Units) by Type (2018-2024)
Table 21. Europe Corticosteroid Medication Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Corticosteroid Medication Sales (K Units) by Type (2018-2024)
Table 23. Asia-Pacific Corticosteroid Medication Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Corticosteroid Medication Sales (K Units) by Type (2018-2024)
Table 25. Latin America Corticosteroid Medication Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Corticosteroid Medication Sales (K Units) by Type (2018-2024)
Table 27. Middle East and Africa Corticosteroid Medication Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Corticosteroid Medication Sales by Company (2018-2024) & (K Units)
Table 29. Global Corticosteroid Medication Sales Share by Company (2018-2024)
Table 30. Global Corticosteroid Medication Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Corticosteroid Medication Revenue Share by Company (2018-2024)
Table 32. Global Market Corticosteroid Medication Price by Company (2018-2024) & (US$/Unit)
Table 33. Global Corticosteroid Medication Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Corticosteroid Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Corticosteroid Medication as of 2022)
Table 36. Date of Key Manufacturers Enter into Corticosteroid Medication Market
Table 37. Key Manufacturers Corticosteroid Medication Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Corticosteroid Medication Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Global Corticosteroid Medication Sales by Region (2018-2024) & (K Units)
Table 41. Global Corticosteroid Medication Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Corticosteroid Medication Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Corticosteroid Medication Sales Market Share in Value by Region (2018-2024)
Table 44. Global Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 45. Global Corticosteroid Medication Sales by Region (2024-2029) & (K Units)
Table 46. Global Corticosteroid Medication Sales Market Share in Volume by Region (2024-2029)
Table 47. Global Corticosteroid Medication Sales by Region (2024-2029) & (US$ Million)
Table 48. Global Corticosteroid Medication Sales Market Share in Value by Region (2024-2029)
Table 49. Global Corticosteroid Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 50. Global Corticosteroid Medication Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. Global Corticosteroid Medication Sales by Application (2018-2024) & (K Units)
Table 52. Global Corticosteroid Medication Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Corticosteroid Medication Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Corticosteroid Medication Sales Market Share in Value by Application (2018-2024)
Table 55. Global Corticosteroid Medication Price by Application (2018-2024) & (US$/Unit)
Table 56. Global Corticosteroid Medication Sales by Application (2024-2029) & (K Units)
Table 57. Global Corticosteroid Medication Sales Market Share in Volume by Application (2024-2029)
Table 58. Global Corticosteroid Medication Sales by Application (2024-2029) & (US$ Million)
Table 59. Global Corticosteroid Medication Sales Market Share in Value by Application (2024-2029)
Table 60. Global Corticosteroid Medication Price by Application (2024-2029) & (US$/Unit)
Table 61. North America Corticosteroid Medication Sales by Application (2018-2024) (K Units)
Table 62. North America Corticosteroid Medication Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Corticosteroid Medication Sales by Application (2018-2024) (K Units)
Table 64. Europe Corticosteroid Medication Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Corticosteroid Medication Sales by Application (2018-2024) (K Units)
Table 66. Asia-Pacific Corticosteroid Medication Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Corticosteroid Medication Sales by Application (2018-2024) (K Units)
Table 68. Latin America Corticosteroid Medication Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Corticosteroid Medication Sales by Application (2018-2024) (K Units)
Table 70. Middle East and Africa Corticosteroid Medication Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Corticosteroid Medication Sales by Country (2018-2024) & (K Units)
Table 72. North America Corticosteroid Medication Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Corticosteroid Medication Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Corticosteroid Medication Sales Market Share in Value by Country (2018-2024)
Table 75. North America Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 76. North America Corticosteroid Medication Sales Market Share in Volume by Country (2024-2029)
Table 77. North America Corticosteroid Medication Sales by Country (2024-2029) & (US$ Million)
Table 78. North America Corticosteroid Medication Sales Market Share in Value by Country (2024-2029)
Table 79. Europe Corticosteroid Medication Sales by Country (2018-2024) & (K Units)
Table 80. Europe Corticosteroid Medication Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Corticosteroid Medication Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Corticosteroid Medication Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 84. Europe Corticosteroid Medication Sales Market Share in Volume by Country (2024-2029)
Table 85. Europe Corticosteroid Medication Sales by Country (2024-2029) & (US$ Million)
Table 86. Europe Corticosteroid Medication Sales Market Share in Value by Country (2024-2029)
Table 87. Asia-Pacific Corticosteroid Medication Sales by Region (2018-2024) & (K Units)
Table 88. Asia-Pacific Corticosteroid Medication Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Corticosteroid Medication Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Corticosteroid Medication Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Corticosteroid Medication Sales by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Corticosteroid Medication Sales Market Share in Volume by Region (2024-2029)
Table 93. Asia-Pacific Corticosteroid Medication Sales by Region (2024-2029) & (US$ Million)
Table 94. Asia-Pacific Corticosteroid Medication Sales Market Share in Value by Region (2024-2029)
Table 95. Latin America Corticosteroid Medication Sales by Country (2018-2024) & (K Units)
Table 96. Latin America Corticosteroid Medication Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Corticosteroid Medication Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Corticosteroid Medication Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 100. Latin America Corticosteroid Medication Sales Market Share in Volume by Country (2024-2029)
Table 101. Latin America Corticosteroid Medication Sales by Country (2024-2029) & (US$ Million)
Table 102. Latin America Corticosteroid Medication Sales Market Share in Value by Country (2024-2029)
Table 103. Middle East and Africa Corticosteroid Medication Sales by Country (2018-2024) & (K Units)
Table 104. Middle East and Africa Corticosteroid Medication Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Corticosteroid Medication Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Corticosteroid Medication Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Corticosteroid Medication Sales by Country (2024-2029) & (K Units)
Table 108. Middle East and Africa Corticosteroid Medication Sales Market Share in Volume by Country (2024-2029)
Table 109. Middle East and Africa Corticosteroid Medication Sales by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Corticosteroid Medication Sales Market Share in Value by Country (2024-2029)
Table 111. Sumitomo Company Information
Table 112. Sumitomo Introduction and Business Overview
Table 113. Sumitomo Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 114. Sumitomo Corticosteroid Medication Product
Table 115. Sumitomo Recent Development
Table 116. Pfizer Company Information
Table 117. Pfizer Introduction and Business Overview
Table 118. Pfizer Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 119. Pfizer Corticosteroid Medication Product
Table 120. Pfizer Recent Development
Table 121. Novartis Company Information
Table 122. Novartis Introduction and Business Overview
Table 123. Novartis Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 124. Novartis Corticosteroid Medication Product
Table 125. Novartis Recent Development
Table 126. Merck Company Information
Table 127. Merck Introduction and Business Overview
Table 128. Merck Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 129. Merck Corticosteroid Medication Product
Table 130. Merck Recent Development
Table 131. Sanofi Company Information
Table 132. Sanofi Introduction and Business Overview
Table 133. Sanofi Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 134. Sanofi Corticosteroid Medication Product
Table 135. Sanofi Recent Development
Table 136. Johnson & Johnson Company Information
Table 137. Johnson & Johnson Introduction and Business Overview
Table 138. Johnson & Johnson Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 139. Johnson & Johnson Corticosteroid Medication Product
Table 140. Johnson & Johnson Recent Development
Table 141. GSK Company Information
Table 142. GSK Introduction and Business Overview
Table 143. GSK Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 144. GSK Corticosteroid Medication Product
Table 145. GSK Recent Development
Table 146. AstraZeneca Company Information
Table 147. AstraZeneca Introduction and Business Overview
Table 148. AstraZeneca Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 149. AstraZeneca Corticosteroid Medication Product
Table 150. AstraZeneca Recent Development
Table 151. Cipla Company Information
Table 152. Cipla Introduction and Business Overview
Table 153. Cipla Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 154. Cipla Corticosteroid Medication Product
Table 155. Cipla Recent Development
Table 156. LEO Pharma Company Information
Table 157. LEO Pharma Introduction and Business Overview
Table 158. LEO Pharma Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 159. LEO Pharma Corticosteroid Medication Product
Table 160. LEO Pharma Recent Development
Table 161. Abbott Laboratories Company Information
Table 162. Abbott Laboratories Introduction and Business Overview
Table 163. Abbott Laboratories Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 164. Abbott Laboratories Corticosteroid Medication Product
Table 165. Abbott Laboratories Recent Development
Table 166. Bayer Company Information
Table 167. Bayer Introduction and Business Overview
Table 168. Bayer Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 169. Bayer Corticosteroid Medication Product
Table 170. Bayer Recent Development
Table 171. Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information
Table 172. Tianjin Tianyao Pharmaceuticals Co., Ltd. Introduction and Business Overview
Table 173. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 174. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product
Table 175. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Development
Table 176. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
Table 177. Zhejiang Xianju Pharmaceutical Co.,Ltd Introduction and Business Overview
Table 178. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 179. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product
Table 180. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development
Table 181. Shandong Xinhua Pharmaceutical Company Limited Company Information
Table 182. Shandong Xinhua Pharmaceutical Company Limited Introduction and Business Overview
Table 183. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 184. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product
Table 185. Shandong Xinhua Pharmaceutical Company Limited Recent Development
Table 186. Yangzi River Pharmaceutical Group Company Information
Table 187. Yangzi River Pharmaceutical Group Introduction and Business Overview
Table 188. Yangzi River Pharmaceutical Group Corticosteroid Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 189. Yangzi River Pharmaceutical Group Corticosteroid Medication Product
Table 190. Yangzi River Pharmaceutical Group Recent Development
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Corticosteroid Medication Market Trends
Table 194. Corticosteroid Medication Market Drivers
Table 195. Corticosteroid Medication Market Challenges
Table 196. Corticosteroid Medication Market Restraints
Table 197. Corticosteroid Medication Distributors List
Table 198. Corticosteroid Medication Downstream Customers
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Corticosteroid Medication Product Picture
Figure 2. Global Corticosteroid Medication Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Corticosteroid Medication Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Corticosteroid Medication Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Tablets
Figure 6. Global Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Capsules
Figure 8. Global Capsules Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Eye Drops
Figure 10. Global Eye Drops Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Lotions, Creams, Ointments, or Gels
Figure 12. Global Lotions, Creams, Ointments, or Gels Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Nasal or Mouth Sprays
Figure 14. Global Nasal or Mouth Sprays Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Product Picture of Injections
Figure 16. Global Injections Sales YoY Growth (2018-2029) & (K Units)
Figure 17. Global Corticosteroid Medication Sales by Type (2018-2029) & (US$ Million)
Figure 18. Global Corticosteroid Medication Sales Market Share by Type in 2022 & 2029
Figure 19. North America Corticosteroid Medication Sales Market Share in Volume by Type in 2022
Figure 20. North America Corticosteroid Medication Sales Market Share in Value by Type in 2022
Figure 21. Europe Corticosteroid Medication Sales Market Share in Volume by Type in 2022
Figure 22. Europe Corticosteroid Medication Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Corticosteroid Medication Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Corticosteroid Medication Sales Market Share in Value by Type in 2022
Figure 25. Latin America Corticosteroid Medication Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Corticosteroid Medication Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Corticosteroid Medication Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Corticosteroid Medication Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Corticosteroid Medication Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Corticosteroid Medication Revenue in 2022
Figure 31. Corticosteroid Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Pharmacy
Figure 37. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Global Corticosteroid Medication Sales by Application (2018-2029) & (US$ Million)
Figure 39. Global Corticosteroid Medication Sales Market Share by Application in 2022 & 2029
Figure 40. North America Corticosteroid Medication Sales Market Share in Volume by Application in 2022
Figure 41. North America Corticosteroid Medication Sales Market Share in Value by Application in 2022
Figure 42. Europe Corticosteroid Medication Sales Market Share in Volume by Application in 2022
Figure 43. Europe Corticosteroid Medication Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Corticosteroid Medication Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Corticosteroid Medication Sales Market Share in Value by Application in 2022
Figure 46. Latin America Corticosteroid Medication Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Corticosteroid Medication Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Corticosteroid Medication Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Corticosteroid Medication Manufacturing Cost Structure
Figure 51. Corticosteroid Medication Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries